(Q45420569)

English

Characterization of naturally occurring and Lamivudine-induced surface gene mutants of hepatitis B virus in patients with chronic hepatitis B in India

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Characterization of naturally occurring and Lamivudine-induced surface gene mutants of hepatitis B virus in patients with chronic hepatitis B in India (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1 reference

based on heuristic

inferred from title

Hepatitis B virus

1 reference

based on heuristic

inferred from title

chronic hepatitis B

1 reference

based on heuristic

inferred from title

author name string

Syed Naqui Kazim

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Shiv Kumar Sarin

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Barjesh Chander Sharma

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Luqman Ahmad Khan

4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Seyed Ehtesham Hasnain

5

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

publication date

1 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

49

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

152-160

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Hepatitis B virus immunopathogenesis

1 reference

https://api.crossref.org/works/10.1159%2F000089376

21 January 2018

Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo

1 reference

https://api.crossref.org/works/10.1159%2F000089376

21 January 2018

Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation

1 reference

https://api.crossref.org/works/10.1159%2F000089376

21 January 2018

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1159%2F000089376

21 January 2018

Clearance of the original hepatitis B virus YMDD-motif mutants with emergence of distinct lamivudine-resistant mutants during prolonged lamivudine therapy

1 reference

https://api.crossref.org/works/10.1159%2F000089376

21 January 2018

Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes.

1 reference

https://api.crossref.org/works/10.1159%2F000089376

21 January 2018

Evolution of hepatitis B virus polymerase gene mutations in hepatitis B e antigen-negative patients receiving lamivudine therapy.

1 reference

https://api.crossref.org/works/10.1159%2F000089376

21 January 2018

Hepatitis B virus surface antigen and polymerase gene variants: potential virological and clinical significance

1 reference

https://api.crossref.org/works/10.1159%2F000089376

21 January 2018

Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy

1 reference

https://api.crossref.org/works/10.1159%2F000089376

21 January 2018

Discontinuous epitopes of hepatitis B surface antigen derived from a filamentous phage peptide library

1 reference

https://api.crossref.org/works/10.1159%2F000089376

21 January 2018

Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation

1 reference

https://api.crossref.org/works/10.1159%2F000089376

21 January 2018

Transient selection of a hepatitis B virus polymerase gene mutant associated with a decreased replication capacity and famciclovir resistance

1 reference

https://api.crossref.org/works/10.1159%2F000089376

21 January 2018

Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective

1 reference

https://api.crossref.org/works/10.1159%2F000089376

21 January 2018

Drug therapy for chronic hepatitis B: antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy.

1 reference

https://api.crossref.org/works/10.1159%2F000089376

21 January 2018

The hepatitis B virus

1 reference

https://api.crossref.org/works/10.1159%2F000089376

21 January 2018

Identifiers

10.1159/000089376

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45420569&oldid=2076903198"